Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$324M |
| 2 |
HP
HPQ
|
+$217M |
| 3 |
AbbVie
ABBV
|
+$202M |
| 4 |
Lowe's Companies
LOW
|
+$163M |
| 5 |
CVS Health
CVS
|
+$161M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$205M |
| 2 |
PepsiCo
PEP
|
+$202M |
| 3 |
Tyson Foods
TSN
|
+$194M |
| 4 |
Everest Group
EG
|
+$186M |
| 5 |
Synchrony
SYF
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.04% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 13.45% |
| 4 | Financials | 10.25% |
| 5 | Consumer Staples | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Equifax
EFX
$22.7B
| $421K | ﹤0.01% |
2,489
-164
| -6% | -$24.3K |
|
1802
eGain
EGAN
$199M
| $421K | ﹤0.01% |
37,923
-150,572
| -80% | -$1.37M |
|
1803
Kodiak Sciences
KOD
$2.36B
| $420K | ﹤0.01% |
+7,758
| New | +$438K |
|
|
SYRS
1804
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $417K | ﹤0.01% |
3,913
+2,450
| +167% | +$220K |
|
1805
ATN International
ATNI
$485M
| $416K | ﹤0.01% |
6,867
-28,253
| -80% | -$1.7M |
|
|
EVRI
1806
DELISTED
Everi Holdings
EVRI
| $416K | ﹤0.01% |
80,590
-398,009
| -83% | -$2.02M |
|
1807
LifeVantage
LFVN
$85.2M
| $416K | ﹤0.01% |
30,771
-6,432
| -17% | -$89.2K |
|
1808
Mativ Holdings
MATV
$688M
| $416K | ﹤0.01% |
12,448
-2,839
| -19% | -$85.5K |
|
|
NPKI
1809
NPK International
NPKI
$1.13B
| $416K | ﹤0.01% |
186,491
+139,646
| +298% | +$236K |
|
|
TLRD
1810
DELISTED
Tailored Brands, Inc.
TLRD
| $414K | ﹤0.01% |
+441,883
| New | +$585K |
|
|
RCM
1811
DELISTED
R1 RCM Inc. Common Stock
RCM
| $410K | ﹤0.01% |
36,756
-10,223
| -22% | -$105K |
|
|
SPNE
1812
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $410K | ﹤0.01% |
39,121
+27,943
| +250% | +$286K |
|
1813
Ollie's Bargain Outlet
OLLI
$4.62B
| $409K | ﹤0.01% |
4,184
-8,369
| -67% | -$643K |
|
1814
Inseego
INSG
$73.2M
| $407K | ﹤0.01% |
3,508
+423
| +14% | +$44.7K |
|
|
TCO
1815
DELISTED
Taubman Centers Inc.
TCO
| $407K | ﹤0.01% |
+10,780
| New | +$441K |
|
|
BITA
1816
DELISTED
Bitauto Holdings Limited
BITA
| $407K | ﹤0.01% |
25,692
| – | – |
|
1817
Tennant Co
TNC
$1.17B
| $405K | ﹤0.01% |
6,229
+1,838
| +42% | +$112K |
|
|
CIVI
1818
DELISTED
Civitas Resources
CIVI
| $404K | ﹤0.01% |
27,275
+14,623
| +116% | +$238K |
|
1819
Gerdau
GGB
$8.73B
| $402K | ﹤0.01% |
171,053
-174,263
| -50% | -$331K |
|
1820
Tilly's
TLYS
$119M
| $400K | ﹤0.01% |
70,597
-410,782
| -85% | -$2.12M |
|
|
NP
1821
DELISTED
Neenah, Inc. Common Stock
NP
| $399K | ﹤0.01% |
8,064
-5,528
| -41% | -$266K |
|
|
ODT
1822
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $399K | ﹤0.01% |
9,430
+88
| +0.9% | +$2.85K |
|
|
FLXN
1823
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $398K | ﹤0.01% |
30,282
+17,395
| +135% | +$180K |
|
1824
Red Rock Resorts
RRR
$3.63B
| $396K | ﹤0.01% |
+36,278
| New | +$410K |
|
1825
Truist Financial
TFC
$62.1B
| $396K | ﹤0.01% |
10,749
-154,545
| -93% | -$5.57M |
|
Similar funds
Cliff Asness's Q2 2020 Portfolio in Review
As of Q2 2020, Cliff Asness held 2,214 positions worth $61.8B, up 4% from $59.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cliff Asness withdrew a net $8.64B in Q2 2020, closing 116 positions and reducing 1,166 holdings. Its most notable exit was United Airlines, an estimated $116M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Cliff Asness opened a new position in Hexcel worth $31.6M.
- Cliff Asness's largest Q2 2020 buy was Hexcel: 698,621 shares worth $31.6M.
- Cliff Asness added most to Amazon in Q2 2020, an estimated $324M increase.
- Cliff Asness's biggest Q2 2020 reduction was Starbucks, cutting an estimated $205M.
- Cliff Asness fully exited United Airlines in Q2 2020, selling an estimated $116M.
- Cliff Asness's ten largest holdings make up 19% of its $61.8B portfolio in Q2 2020.
- Cliff Asness opened 182 new positions and closed 116 in Q2 2020.
- Cliff Asness's portfolio value rose 4% quarter-over-quarter to $61.8B.
Based on AQR Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.